First-line nivolumab monotherapy and nivolumab plus ipilimumab in patients with advanced NSCLC: Long-term outcomes from CheckMate 012 Meeting Abstract

  


Authors: Gettinger, S.; Rizvi, N.; Chow, L.; Borghaei, H.; Brahmer, J.; Shepherd, F.; Ready, N.; Gerber, D.; Antonia, S.; Goldman, J. W.; Juergens, R.; Geese, W.; Young, T.; Li, X.; Hellmann, M.
Abstract Title: First-line nivolumab monotherapy and nivolumab plus ipilimumab in patients with advanced NSCLC: Long-term outcomes from CheckMate 012
Meeting Title: IASLC 17th World Conference on Lung Cancer
Keywords: survival; monotherapy; nsclc; nivolumab
Journal Title: Journal of Thoracic Oncology
Volume: 12
Issue: 1 Suppl.
Meeting Dates: 2016 Dec 4-7
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2017-01-01
Start Page: S250
End Page: S251
Language: English
ACCESSION: WOS:000413055800226
PROVIDER: wos
DOI: 10.1016/j.jtho.2016.11.238
Notes: Meeting Abstract: OA03.01 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Naiyer A Rizvi
    166 Rizvi
  2. Matthew David Hellmann
    411 Hellmann
Related MSK Work